Digit Bio is a startup based in the United States.
Digit Bio develops molecular engineering technologies that enable high-resolution functional screening and characterization of biological medicines directly within cellular and tissue systems to optimize next-generation therapies.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.